{"id":3103,"date":"2014-02-05T20:07:45","date_gmt":"2014-02-05T18:07:45","guid":{"rendered":"http:\/\/www.ced.org.tr\/?p=3103"},"modified":"2014-02-05T20:07:45","modified_gmt":"2014-02-05T18:07:45","slug":"ilac-devi-bayerden-itiraf-kanser-ilacini-zenginler-icin-gelistirdik","status":"publish","type":"post","link":"http:\/\/www.ced.org.tr\/?p=3103","title":{"rendered":"\u0130la\u00e7 devi Bayer&#8217;den itiraf: Kanser ilac\u0131n\u0131 zenginler i\u00e7in geli\u015ftirdik"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"background: white;\"><strong><span style=\"font-size: 11.0pt; font-family: Arial; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-bidi-font-family: &quot;Times New Roman&quot;; color: #222222; mso-ansi-language: EN-US;\">Bayer firmas\u0131n\u0131n kanser ilac\u0131 Nexavar i\u00e7in hasta ba\u015f\u0131na y\u0131lda 67 bin dolar talep etti\u011fi belirtildi. Firman\u0131n CEO&#8217;su Marjin Dekkers, &#8216;\u0130lac\u0131 Hintliler i\u00e7in de\u011fil, zengin Bat\u0131l\u0131lar i\u00e7in geli\u015ftirdik&#8217; dedi. <\/span><\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p>\u00a0<\/p>\n<p class=\"MsoNormal\" style=\"background: white;\"><span style=\"font-size: 11.0pt; font-family: Arial; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-bidi-font-family: &quot;Times New Roman&quot;; color: #222222; mso-ansi-language: EN-US;\"><span style=\"color: #1155cc;\"><a href=\"http:\/\/www.radikal.com.tr\/dunya\/ilac_devi_bayerden_itiraf_kanser_ilacini_zenginler_icin_gelistirdik-1174230\">http:\/\/www.radikal.com.tr\/dunya\/ilac_devi_bayerden_itiraf_kanser_ilacini_zenginler_icin_gelistirdik-1174230<\/a><\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; background: white;\"><strong><span style=\"font-size: 11.0pt; font-family: Arial; mso-bidi-font-family: &quot;Times New Roman&quot;; color: #222222; mso-ansi-language: EN-US;\"><a href=\"http:\/\/radikal.com.tr\/\"><span style=\"color: #1155cc;\">Radikal.com.tr<\/span><\/a> &#8211; <\/span><\/strong><span style=\"font-size: 11.0pt; font-family: Arial; mso-bidi-font-family: &quot;Times New Roman&quot;; color: #222222; mso-ansi-language: EN-US;\">Bir\u00e7ok sivil toplum kurulu\u015fu, Bayer CEO&#8217;su Marijn Dekkers\u2019in \u201cBiz bu ilac\u0131 Bat\u0131l\u0131 zenginler i\u00e7in \u00fcrettik\u201d a\u00e7\u0131klamalar\u0131 nedeniyle dava a\u00e7aca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. Bayer yetkilileri Dekkers\u2019in a\u00e7\u0131klamalar\u0131n\u0131n yanl\u0131\u015f anla\u015f\u0131ld\u0131\u011f\u0131n\u0131 iddia etse de bu a\u00e7\u0131klama kabul g\u00f6rmedi. Dekkers\u2019in ge\u00e7en aral\u0131k ay\u0131nda FT Pharma Konferans\u0131\u2019nda yapt\u0131\u011f\u0131 konu\u015fmadaki s\u00f6zleri, haftal\u0131k Amerikan dergisi Business Week\u2019in bu s\u00f6zlere son say\u0131s\u0131nda yer vermesiyle duyuldu.\u00a0<\/p>\n<p> HaberT\u00fcrk&#8217;te yer alan habere g\u00f6re, Hindistan h\u00fck\u00fcmetinin b\u00f6brek, karaci\u011fer ve tiroit kanseri tedavisinde kullan\u0131lan ilac\u0131n patentsiz \u00fcretimine izin vermesine tepki g\u00f6steren Dekkers, bunun asl\u0131nda \u201ch\u0131rs\u0131zl\u0131k\u201d oldu\u011funu ileri s\u00fcrd\u00fc ve \u201cBiz bu \u00fcr\u00fcn\u00fc Hindistan pazar\u0131 i\u00e7in geli\u015ftirmedik. Bu \u00fcr\u00fcn\u00fc do\u011frusunu s\u00f6ylemek gerekirse Bat\u0131\u2019daki bunu alabilecek maddi g\u00fcce sahip insanlar i\u00e7in geli\u015ftirdik\u201d ifadesini kulland\u0131. Bayer firmas\u0131n\u0131n s\u00f6z konusu kanser ilac\u0131 i\u00e7in hasta ba\u015f\u0131na y\u0131lda 96 bin dolar talep etti\u011fine, Hindistan\u2019da da \u00fcretilmeye ba\u015flanan ilac\u0131n ise sadece 177 dolara sat\u0131ld\u0131\u011f\u0131na dikkat \u00e7ekildi.<\/span><span style=\"font-size: 11pt;\"> <\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bayer firmas\u0131n\u0131n kanser ilac\u0131 Nexavar i\u00e7in hasta ba\u015f\u0131na y\u0131lda 67 bin dolar talep etti\u011fi belirtildi. Firman\u0131n CEO&#8217;su Marjin Dekkers, &#8216;\u0130lac\u0131&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_monsterinsights_skip_tracking":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[62],"tags":[],"class_list":["post-3103","post","type-post","status-publish","format-standard","hentry","category-sagliktan-haberler"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.3 - aioseo.com -->\n\t<meta name=\"description\" content=\"Bayer firmas\u0131n\u0131n kanser ilac\u0131 Nexavar i\u00e7in hasta ba\u015f\u0131na y\u0131lda 67 bin dolar talep etti\u011fi belirtildi. Firman\u0131n CEO&#039;su Marjin Dekkers, &#039;\u0130lac\u0131 Hintliler i\u00e7in de\u011fil, zengin Bat\u0131l\u0131lar i\u00e7in geli\u015ftirdik&#039; dedi. http:\/\/www.radikal.com.tr\/dunya\/ilac_devi_bayerden_itiraf_kanser_ilacini_zenginler_icin_gelistirdik-1174230 Radikal.com.tr - Bir\u00e7ok sivil toplum kurulu\u015fu, Bayer CEO&#039;su Marijn Dekkers\u2019in \u201cBiz bu ilac\u0131 Bat\u0131l\u0131 zenginler i\u00e7in \u00fcrettik\u201d a\u00e7\u0131klamalar\u0131 nedeniyle dava a\u00e7aca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. Bayer yetkilileri Dekkers\u2019in\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"CED \u0130STANBUL\"\/>\n\t<meta name=\"google-site-verification\" content=\"4\/PADeybIVXNi1FWDn2PVVeqiyUv8gGZqu7DNmOEZBNDKJiHEdIk47RKA\" \/>\n\t<meta name=\"msvalidate.01\" content=\"4\/PADeybIVXNi1FWDn2PVVeqiyUv8gGZqu7DNmOEZBNDKJiHEdIk47RKA\" \/>\n\t<meta name=\"p:domain_verify\" content=\"-01Tt29FgD8frNEEpRik8kzbF8-9TRCVGsm93a0wCBA\" \/>\n\t<meta name=\"keywords\" content=\"sa\u011fl\u0131ktan haberler\" \/>\n\t<link rel=\"canonical\" href=\"http:\/\/www.ced.org.tr\/?p=3103\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.3\" \/>\n\n\t\t<meta name=\"google-site-verification\" content=\"-01Tt29FgD8frNEEpRik8kzbF8-9TRCVGsm93a0wCBA\" \/>\n\t\t<meta property=\"og:locale\" content=\"tr_TR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"\u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"\u0130la\u00e7 devi Bayer\u2019den itiraf: Kanser ilac\u0131n\u0131 zenginler i\u00e7in geli\u015ftirdik | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi\" \/>\n\t\t<meta property=\"og:description\" content=\"Bayer firmas\u0131n\u0131n kanser ilac\u0131 Nexavar i\u00e7in hasta ba\u015f\u0131na y\u0131lda 67 bin dolar talep etti\u011fi belirtildi. Firman\u0131n CEO&#039;su Marjin Dekkers, &#039;\u0130lac\u0131 Hintliler i\u00e7in de\u011fil, zengin Bat\u0131l\u0131lar i\u00e7in geli\u015ftirdik&#039; dedi. http:\/\/www.radikal.com.tr\/dunya\/ilac_devi_bayerden_itiraf_kanser_ilacini_zenginler_icin_gelistirdik-1174230 Radikal.com.tr - Bir\u00e7ok sivil toplum kurulu\u015fu, Bayer CEO&#039;su Marijn Dekkers\u2019in \u201cBiz bu ilac\u0131 Bat\u0131l\u0131 zenginler i\u00e7in \u00fcrettik\u201d a\u00e7\u0131klamalar\u0131 nedeniyle dava a\u00e7aca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. Bayer yetkilileri Dekkers\u2019in\" \/>\n\t\t<meta property=\"og:url\" content=\"http:\/\/www.ced.org.tr\/?p=3103\" \/>\n\t\t<meta property=\"fb:app_id\" content=\"1929982940611222\" \/>\n\t\t<meta property=\"fb:admins\" content=\"343956055774962,212758298769685,1829947477319551\" \/>\n\t\t<meta property=\"og:image\" content=\"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2021\/07\/cropped-cropped-CEDLOGO.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"208\" \/>\n\t\t<meta property=\"og:image:height\" content=\"144\" \/>\n\t\t<meta property=\"article:tag\" content=\"sa\u011fl\u0131ktan haberler\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2014-02-05T18:07:45+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2014-02-05T18:07:45+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/groups\/1502807510044536\/\" \/>\n\t\t<meta property=\"article:author\" content=\"http:\/\/\u00c7a\u011fda\u015f%20Eczac\u0131lar%20\u0130stanbul\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@CagdasEczacilar\" \/>\n\t\t<meta name=\"twitter:title\" content=\"\u0130la\u00e7 devi Bayer\u2019den itiraf: Kanser ilac\u0131n\u0131 zenginler i\u00e7in geli\u015ftirdik | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Bayer firmas\u0131n\u0131n kanser ilac\u0131 Nexavar i\u00e7in hasta ba\u015f\u0131na y\u0131lda 67 bin dolar talep etti\u011fi belirtildi. Firman\u0131n CEO&#039;su Marjin Dekkers, &#039;\u0130lac\u0131 Hintliler i\u00e7in de\u011fil, zengin Bat\u0131l\u0131lar i\u00e7in geli\u015ftirdik&#039; dedi. http:\/\/www.radikal.com.tr\/dunya\/ilac_devi_bayerden_itiraf_kanser_ilacini_zenginler_icin_gelistirdik-1174230 Radikal.com.tr - Bir\u00e7ok sivil toplum kurulu\u015fu, Bayer CEO&#039;su Marijn Dekkers\u2019in \u201cBiz bu ilac\u0131 Bat\u0131l\u0131 zenginler i\u00e7in \u00fcrettik\u201d a\u00e7\u0131klamalar\u0131 nedeniyle dava a\u00e7aca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. Bayer yetkilileri Dekkers\u2019in\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@CEDistanbul\" \/>\n\t\t<meta name=\"twitter:image\" content=\"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2021\/07\/CEDLOGO.jpg\" \/>\n\t\t<meta name=\"twitter:label1\" content=\"Taraf\u0131ndan yaz\u0131lm\u0131\u015ft\u0131r\" \/>\n\t\t<meta name=\"twitter:data1\" content=\"CED \u0130STANBUL\" \/>\n\t\t<meta name=\"twitter:label2\" content=\"Est. okuma zaman\u0131\" \/>\n\t\t<meta name=\"twitter:data2\" content=\"1 dakika\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3103#article\",\"name\":\"\\u0130la\\u00e7 devi Bayer\\u2019den itiraf: Kanser ilac\\u0131n\\u0131 zenginler i\\u00e7in geli\\u015ftirdik | \\u00c7a\\u011fda\\u015f Eczac\\u0131lar Derne\\u011fi\",\"headline\":\"\\u0130la\\u00e7 devi Bayer&#8217;den itiraf: Kanser ilac\\u0131n\\u0131 zenginler i\\u00e7in geli\\u015ftirdik\",\"author\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1#author\"},\"publisher\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/wp-content\\\/uploads\\\/2014\\\/05\\\/ced_favicon.png\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#articleImage\",\"width\":160,\"height\":169},\"datePublished\":\"2014-02-05T20:07:45+02:00\",\"dateModified\":\"2014-02-05T20:07:45+02:00\",\"inLanguage\":\"tr-TR\",\"mainEntityOfPage\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3103#webpage\"},\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3103#webpage\"},\"articleSection\":\"Sa\\u011fl\\u0131ktan Haberler\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3103#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#listItem\",\"position\":1,\"name\":\"Ev\",\"item\":\"http:\\\/\\\/www.ced.org.tr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=1#listItem\",\"name\":\"\\u00c7ED\"}},{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=1#listItem\",\"position\":2,\"name\":\"\\u00c7ED\",\"item\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=1\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=62#listItem\",\"name\":\"Sa\\u011fl\\u0131ktan Haberler\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#listItem\",\"name\":\"Ev\"}},{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=62#listItem\",\"position\":3,\"name\":\"Sa\\u011fl\\u0131ktan Haberler\",\"item\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=62\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3103#listItem\",\"name\":\"\\u0130la\\u00e7 devi Bayer&#8217;den itiraf: Kanser ilac\\u0131n\\u0131 zenginler i\\u00e7in geli\\u015ftirdik\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=1#listItem\",\"name\":\"\\u00c7ED\"}},{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3103#listItem\",\"position\":4,\"name\":\"\\u0130la\\u00e7 devi Bayer&#8217;den itiraf: Kanser ilac\\u0131n\\u0131 zenginler i\\u00e7in geli\\u015ftirdik\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=62#listItem\",\"name\":\"Sa\\u011fl\\u0131ktan Haberler\"}}]},{\"@type\":\"Organization\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#organization\",\"name\":\"\\u00c7A\\u011eDA\\u015e ECZACILAR DERNE\\u011e\\u0130\",\"description\":\"Herkes i\\u00e7in e\\u015fit, paras\\u0131z, ula\\u015f\\u0131labilir bir sa\\u011fl\\u0131k hizmeti\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/wp-content\\\/uploads\\\/2014\\\/05\\\/ced_favicon.png\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3103\\\/#organizationLogo\",\"width\":160,\"height\":169},\"image\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3103\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/groups\\\/1502807510044536\\\/\",\"https:\\\/\\\/twitter.com\\\/CagdasEczacilar\",\"https:\\\/\\\/www.instagram.com\\\/cagdaseczacilaristanbul\\\/\"]},{\"@type\":\"Person\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1#author\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1\",\"name\":\"CED \\u0130STANBUL\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3103#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/268db36756a52d57bae55f9ffde5852f0c9bbd270ed5c7941979e1563edc6d07?s=96&d=retro&r=g\",\"width\":96,\"height\":96,\"caption\":\"CED \\u0130STANBUL\"},\"sameAs\":[\"http:\\\/\\\/\\u00c7a\\u011fda\\u015f%20Eczac\\u0131lar%20\\u0130stanbul\",\"@CEDistanbul\"]},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3103#webpage\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3103\",\"name\":\"\\u0130la\\u00e7 devi Bayer\\u2019den itiraf: Kanser ilac\\u0131n\\u0131 zenginler i\\u00e7in geli\\u015ftirdik | \\u00c7a\\u011fda\\u015f Eczac\\u0131lar Derne\\u011fi\",\"description\":\"Bayer firmas\\u0131n\\u0131n kanser ilac\\u0131 Nexavar i\\u00e7in hasta ba\\u015f\\u0131na y\\u0131lda 67 bin dolar talep etti\\u011fi belirtildi. Firman\\u0131n CEO'su Marjin Dekkers, '\\u0130lac\\u0131 Hintliler i\\u00e7in de\\u011fil, zengin Bat\\u0131l\\u0131lar i\\u00e7in geli\\u015ftirdik' dedi. http:\\\/\\\/www.radikal.com.tr\\\/dunya\\\/ilac_devi_bayerden_itiraf_kanser_ilacini_zenginler_icin_gelistirdik-1174230 Radikal.com.tr - Bir\\u00e7ok sivil toplum kurulu\\u015fu, Bayer CEO'su Marijn Dekkers\\u2019in \\u201cBiz bu ilac\\u0131 Bat\\u0131l\\u0131 zenginler i\\u00e7in \\u00fcrettik\\u201d a\\u00e7\\u0131klamalar\\u0131 nedeniyle dava a\\u00e7aca\\u011f\\u0131n\\u0131 a\\u00e7\\u0131klad\\u0131. Bayer yetkilileri Dekkers\\u2019in\",\"inLanguage\":\"tr-TR\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#website\"},\"breadcrumb\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3103#breadcrumblist\"},\"author\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1#author\"},\"creator\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1#author\"},\"datePublished\":\"2014-02-05T20:07:45+02:00\",\"dateModified\":\"2014-02-05T20:07:45+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#website\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/\",\"name\":\"\\u00c7a\\u011fda\\u015f Eczac\\u0131lar Derne\\u011fi\",\"description\":\"Herkes i\\u00e7in e\\u015fit, paras\\u0131z, ula\\u015f\\u0131labilir bir sa\\u011fl\\u0131k hizmeti\",\"inLanguage\":\"tr-TR\",\"publisher\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"\u0130la\u00e7 devi Bayer\u2019den itiraf: Kanser ilac\u0131n\u0131 zenginler i\u00e7in geli\u015ftirdik | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","description":"Bayer firmas\u0131n\u0131n kanser ilac\u0131 Nexavar i\u00e7in hasta ba\u015f\u0131na y\u0131lda 67 bin dolar talep etti\u011fi belirtildi. Firman\u0131n CEO'su Marjin Dekkers, '\u0130lac\u0131 Hintliler i\u00e7in de\u011fil, zengin Bat\u0131l\u0131lar i\u00e7in geli\u015ftirdik' dedi. http:\/\/www.radikal.com.tr\/dunya\/ilac_devi_bayerden_itiraf_kanser_ilacini_zenginler_icin_gelistirdik-1174230 Radikal.com.tr - Bir\u00e7ok sivil toplum kurulu\u015fu, Bayer CEO'su Marijn Dekkers\u2019in \u201cBiz bu ilac\u0131 Bat\u0131l\u0131 zenginler i\u00e7in \u00fcrettik\u201d a\u00e7\u0131klamalar\u0131 nedeniyle dava a\u00e7aca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. Bayer yetkilileri Dekkers\u2019in","canonical_url":"http:\/\/www.ced.org.tr\/?p=3103","robots":"max-image-preview:large","keywords":"sa\u011fl\u0131ktan haberler","webmasterTools":{"google-site-verification":"4\/PADeybIVXNi1FWDn2PVVeqiyUv8gGZqu7DNmOEZBNDKJiHEdIk47RKA","msvalidate.01":"4\/PADeybIVXNi1FWDn2PVVeqiyUv8gGZqu7DNmOEZBNDKJiHEdIk47RKA","p:domain_verify":"-01Tt29FgD8frNEEpRik8kzbF8-9TRCVGsm93a0wCBA","miscellaneous":"&lt;meta name=\"google-site-verification\" content=\"-01Tt29FgD8frNEEpRik8kzbF8-9TRCVGsm93a0wCBA\" \/&gt;"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.ced.org.tr\/?p=3103#article","name":"\u0130la\u00e7 devi Bayer\u2019den itiraf: Kanser ilac\u0131n\u0131 zenginler i\u00e7in geli\u015ftirdik | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","headline":"\u0130la\u00e7 devi Bayer&#8217;den itiraf: Kanser ilac\u0131n\u0131 zenginler i\u00e7in geli\u015ftirdik","author":{"@id":"http:\/\/www.ced.org.tr\/?author=1#author"},"publisher":{"@id":"http:\/\/www.ced.org.tr\/#organization"},"image":{"@type":"ImageObject","url":"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2014\/05\/ced_favicon.png","@id":"http:\/\/www.ced.org.tr\/#articleImage","width":160,"height":169},"datePublished":"2014-02-05T20:07:45+02:00","dateModified":"2014-02-05T20:07:45+02:00","inLanguage":"tr-TR","mainEntityOfPage":{"@id":"http:\/\/www.ced.org.tr\/?p=3103#webpage"},"isPartOf":{"@id":"http:\/\/www.ced.org.tr\/?p=3103#webpage"},"articleSection":"Sa\u011fl\u0131ktan Haberler"},{"@type":"BreadcrumbList","@id":"http:\/\/www.ced.org.tr\/?p=3103#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/#listItem","position":1,"name":"Ev","item":"http:\/\/www.ced.org.tr\/","nextItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=1#listItem","name":"\u00c7ED"}},{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=1#listItem","position":2,"name":"\u00c7ED","item":"http:\/\/www.ced.org.tr\/?cat=1","nextItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=62#listItem","name":"Sa\u011fl\u0131ktan Haberler"},"previousItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/#listItem","name":"Ev"}},{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=62#listItem","position":3,"name":"Sa\u011fl\u0131ktan Haberler","item":"http:\/\/www.ced.org.tr\/?cat=62","nextItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?p=3103#listItem","name":"\u0130la\u00e7 devi Bayer&#8217;den itiraf: Kanser ilac\u0131n\u0131 zenginler i\u00e7in geli\u015ftirdik"},"previousItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=1#listItem","name":"\u00c7ED"}},{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?p=3103#listItem","position":4,"name":"\u0130la\u00e7 devi Bayer&#8217;den itiraf: Kanser ilac\u0131n\u0131 zenginler i\u00e7in geli\u015ftirdik","previousItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=62#listItem","name":"Sa\u011fl\u0131ktan Haberler"}}]},{"@type":"Organization","@id":"http:\/\/www.ced.org.tr\/#organization","name":"\u00c7A\u011eDA\u015e ECZACILAR DERNE\u011e\u0130","description":"Herkes i\u00e7in e\u015fit, paras\u0131z, ula\u015f\u0131labilir bir sa\u011fl\u0131k hizmeti","url":"http:\/\/www.ced.org.tr\/","logo":{"@type":"ImageObject","url":"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2014\/05\/ced_favicon.png","@id":"http:\/\/www.ced.org.tr\/?p=3103\/#organizationLogo","width":160,"height":169},"image":{"@id":"http:\/\/www.ced.org.tr\/?p=3103\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/groups\/1502807510044536\/","https:\/\/twitter.com\/CagdasEczacilar","https:\/\/www.instagram.com\/cagdaseczacilaristanbul\/"]},{"@type":"Person","@id":"http:\/\/www.ced.org.tr\/?author=1#author","url":"http:\/\/www.ced.org.tr\/?author=1","name":"CED \u0130STANBUL","image":{"@type":"ImageObject","@id":"http:\/\/www.ced.org.tr\/?p=3103#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/268db36756a52d57bae55f9ffde5852f0c9bbd270ed5c7941979e1563edc6d07?s=96&d=retro&r=g","width":96,"height":96,"caption":"CED \u0130STANBUL"},"sameAs":["http:\/\/\u00c7a\u011fda\u015f%20Eczac\u0131lar%20\u0130stanbul","@CEDistanbul"]},{"@type":"WebPage","@id":"http:\/\/www.ced.org.tr\/?p=3103#webpage","url":"http:\/\/www.ced.org.tr\/?p=3103","name":"\u0130la\u00e7 devi Bayer\u2019den itiraf: Kanser ilac\u0131n\u0131 zenginler i\u00e7in geli\u015ftirdik | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","description":"Bayer firmas\u0131n\u0131n kanser ilac\u0131 Nexavar i\u00e7in hasta ba\u015f\u0131na y\u0131lda 67 bin dolar talep etti\u011fi belirtildi. Firman\u0131n CEO'su Marjin Dekkers, '\u0130lac\u0131 Hintliler i\u00e7in de\u011fil, zengin Bat\u0131l\u0131lar i\u00e7in geli\u015ftirdik' dedi. http:\/\/www.radikal.com.tr\/dunya\/ilac_devi_bayerden_itiraf_kanser_ilacini_zenginler_icin_gelistirdik-1174230 Radikal.com.tr - Bir\u00e7ok sivil toplum kurulu\u015fu, Bayer CEO'su Marijn Dekkers\u2019in \u201cBiz bu ilac\u0131 Bat\u0131l\u0131 zenginler i\u00e7in \u00fcrettik\u201d a\u00e7\u0131klamalar\u0131 nedeniyle dava a\u00e7aca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. Bayer yetkilileri Dekkers\u2019in","inLanguage":"tr-TR","isPartOf":{"@id":"http:\/\/www.ced.org.tr\/#website"},"breadcrumb":{"@id":"http:\/\/www.ced.org.tr\/?p=3103#breadcrumblist"},"author":{"@id":"http:\/\/www.ced.org.tr\/?author=1#author"},"creator":{"@id":"http:\/\/www.ced.org.tr\/?author=1#author"},"datePublished":"2014-02-05T20:07:45+02:00","dateModified":"2014-02-05T20:07:45+02:00"},{"@type":"WebSite","@id":"http:\/\/www.ced.org.tr\/#website","url":"http:\/\/www.ced.org.tr\/","name":"\u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","description":"Herkes i\u00e7in e\u015fit, paras\u0131z, ula\u015f\u0131labilir bir sa\u011fl\u0131k hizmeti","inLanguage":"tr-TR","publisher":{"@id":"http:\/\/www.ced.org.tr\/#organization"}}]},"og:locale":"tr_TR","og:site_name":"\u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","og:type":"article","og:title":"\u0130la\u00e7 devi Bayer\u2019den itiraf: Kanser ilac\u0131n\u0131 zenginler i\u00e7in geli\u015ftirdik | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","og:description":"Bayer firmas\u0131n\u0131n kanser ilac\u0131 Nexavar i\u00e7in hasta ba\u015f\u0131na y\u0131lda 67 bin dolar talep etti\u011fi belirtildi. Firman\u0131n CEO'su Marjin Dekkers, '\u0130lac\u0131 Hintliler i\u00e7in de\u011fil, zengin Bat\u0131l\u0131lar i\u00e7in geli\u015ftirdik' dedi. http:\/\/www.radikal.com.tr\/dunya\/ilac_devi_bayerden_itiraf_kanser_ilacini_zenginler_icin_gelistirdik-1174230 Radikal.com.tr - Bir\u00e7ok sivil toplum kurulu\u015fu, Bayer CEO'su Marijn Dekkers\u2019in \u201cBiz bu ilac\u0131 Bat\u0131l\u0131 zenginler i\u00e7in \u00fcrettik\u201d a\u00e7\u0131klamalar\u0131 nedeniyle dava a\u00e7aca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. Bayer yetkilileri Dekkers\u2019in","og:url":"http:\/\/www.ced.org.tr\/?p=3103","fb:app_id":"1929982940611222","fb:admins":"343956055774962,212758298769685,1829947477319551","og:image":"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2021\/07\/cropped-cropped-CEDLOGO.jpg","og:image:width":208,"og:image:height":144,"article:tag":["sa\u011fl\u0131ktan haberler"],"article:published_time":"2014-02-05T18:07:45+00:00","article:modified_time":"2014-02-05T18:07:45+00:00","article:publisher":"https:\/\/www.facebook.com\/groups\/1502807510044536\/","article:author":"http:\/\/\u00c7a\u011fda\u015f%20Eczac\u0131lar%20\u0130stanbul","twitter:card":"summary_large_image","twitter:site":"@CagdasEczacilar","twitter:title":"\u0130la\u00e7 devi Bayer\u2019den itiraf: Kanser ilac\u0131n\u0131 zenginler i\u00e7in geli\u015ftirdik | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","twitter:description":"Bayer firmas\u0131n\u0131n kanser ilac\u0131 Nexavar i\u00e7in hasta ba\u015f\u0131na y\u0131lda 67 bin dolar talep etti\u011fi belirtildi. Firman\u0131n CEO'su Marjin Dekkers, '\u0130lac\u0131 Hintliler i\u00e7in de\u011fil, zengin Bat\u0131l\u0131lar i\u00e7in geli\u015ftirdik' dedi. http:\/\/www.radikal.com.tr\/dunya\/ilac_devi_bayerden_itiraf_kanser_ilacini_zenginler_icin_gelistirdik-1174230 Radikal.com.tr - Bir\u00e7ok sivil toplum kurulu\u015fu, Bayer CEO'su Marijn Dekkers\u2019in \u201cBiz bu ilac\u0131 Bat\u0131l\u0131 zenginler i\u00e7in \u00fcrettik\u201d a\u00e7\u0131klamalar\u0131 nedeniyle dava a\u00e7aca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. Bayer yetkilileri Dekkers\u2019in","twitter:creator":"@CEDistanbul","twitter:image":"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2021\/07\/CEDLOGO.jpg","twitter:label1":"Taraf\u0131ndan yaz\u0131lm\u0131\u015ft\u0131r","twitter:data1":"CED \u0130STANBUL","twitter:label2":"Est. okuma zaman\u0131","twitter:data2":"1 dakika"},"aioseo_meta_data":{"post_id":"3103","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":null,"schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2021-01-08 21:37:56","updated":"2025-06-04 01:50:19","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"seo_analyzer_scan_date":null},"jetpack_sharing_enabled":true,"jetpack-related-posts":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3103"}],"version-history":[{"count":0,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3103\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3103"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3103"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}